Skip to content
Search

Latest Stories

Cathy Harrison assumes permanent role as Northern Ireland's Chief Pharmaceutical Officer

Cathy Harrison has been permanently appointed as Northern Ireland's Chief Pharmaceutical Officer.

Harrison, who had been serving as the acting CPO since Dr Mark Timoney stepped down in December 2018, took up her permanent role last week.


She is responsible for leading policy relating to Medicines Optimisation, Innovation, Pharmacist Prescribing, Pharmacy in the Community and Pharmaceutical Public Health.

A qualified pharmacist, Harrison is the registrant of both the Pharmaceutical Society of Northern Ireland and the Royal Pharmaceutical Society of Great Britain.

Speaking at an National Pharmacy Association (NPA) reception in Belfast on Monday, Harrison said the pharmacists’ “skills are increasingly in demand.”

In her first public speech since taking over as permanent CPO, she warned that “pharmacy cannot be the answer to every question” and urged the NPA members to focus on what they do best and make the most of their medicinal expertise.

Harrison also envisaged a positive future for community pharmacy.

Also speaking at the event, Gerard Greene, Chief Executive of Community Pharmacy Northern Ireland said Community pharmacy was “intent on making significant in-roads into the public health, medicines optimisation and transformation agendas”.

NPA Acting Chair Andrew Lane, who hosted the reception, praised both Harrison and Greene for maintaining a constructive dialogue with each other through trying times, noting pressures on workforce and finances.

Co-host Michael Guerin, the NPA’s Treasurer, said he now looked forward to progress in relation to the long-stalled community pharmacy contract in Northern Ireland.

NPA Chief Executive Mark Lyonette also attended the reception.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less